omega-n-methylarginine has been researched along with piperidines in 22 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (piperidines) | Trials (piperidines) | Recent Studies (post-2010) (piperidines) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 40,235 | 5,221 | 14,545 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (50.00) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, DA; Miller, VM | 1 |
| Hiramatsu, Y; Itokazu, Y; Kinoshita, T; Koida, M; Kurio, W; Maeda, H; Manno, K; Nakamuta, H; Ogawa, Y; Ozaki, K | 1 |
| Ferguson, MK; Reeder, LB | 1 |
| Goto, A; Hayakawa, H; Hirata, Y; Hirobe, M; Kakoki, M; Kikuchi, K; Kimura, K; Nagano, T; Nagata, D; Omata, M; Suzuki, E; Tojo, A | 1 |
| Bertrand, C; Emanueli, C; Figini, M; Geppetti, P; Regoli, D; Sicuteri, R | 1 |
| Higashi, T; Ishizaki, T; Nakai, T; Shigemori, K; Yamamura, T | 1 |
| Higuchi, H; Satoh, T | 1 |
| Moore, KA; Taylor, GE; Weinreich, D | 1 |
| Di Maria, GU; Fabbri, LM; Geppetti, P; Rado, V; Ricciardolo, FL; Sterk, PJ | 1 |
| Frasch, HF; Marshall, BE; Marshall, C | 1 |
| Cao, WH; Dewit, D; Ju, KH; Kumada, M; Kuwaki, T; Ling, GY; Ohuchi, T; Onodera, M; Yanagisawa, M | 1 |
| Lee, K; Pinnock, RD; Preston, Z; Richardson, PJ; Widdowson, L | 1 |
| Cannon, RO; Cardillo, C; Kilcoyne, CM; Panza, JA | 1 |
| Lee, BH; Rapoport, RM; Zuccarello, M | 1 |
| Miller, CE; Nankervis, CA; Schauer, GM | 1 |
| Bursell, DK; Bursell, SE; Clermont, AC; King, GL; Mori, F | 1 |
| Chilian, WM; Merkus, D; Nishikawa, Y; Stepp, DW | 1 |
| Grbović, L; Jovanović, A; Pesić, S | 1 |
| Bruck, H; Philipp, T; Schäfers, RF; Siffert, W; Wenzel, RR | 1 |
| Fujii, A; Hirai, K; Hisaichi, K; Kawanaka, Y; Kobayashi, K; Komeno, M; Kusuda, S; Murota, M; Naka, M; Nakai, H; Nishiyama, T; Odagaki, Y; Tatsumi, T; Toda, M | 1 |
| Fujii, A; Hirai, K; Hisaichi, K; Kawanaka, Y; Kobayashi, K; Komeno, M; Kusuda, S; Murota, M; Naka, M; Nakai, H; Nishiyama, T; Tatsumi, T; Toda, M | 1 |
| Barbieri, SF; Brar, BK; Gattuso, A; Mahata, SK; Mannarino, C; Mazza, R; Tota, B | 1 |
22 other study(ies) available for omega-n-methylarginine and piperidines
| Article | Year |
|---|---|
Role of lipoxygenase and cytochrome P-450 in production of endothelium-derived relaxing factors in canine femoral veins.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arginine; Benzoquinones; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Femoral Vein; In Vitro Techniques; Lipoxygenase Inhibitors; Masoprocol; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Piperidines; Proadifen | 1992 |
[Influences of hypercholesterolemia on the vessel function of isolated rat thoracic aorta].
Topics: Acetylcholine; Aging; Animals; Aorta, Thoracic; Arginine; Body Weight; Cholesterol, Dietary; Endothelium, Vascular; Hypercholesterolemia; In Vitro Techniques; Male; Muscle, Smooth, Vascular; omega-N-Methylarginine; Phenylephrine; Piperidines; Pyrimidinones; Rats; Rats, Inbred Strains; Vasoconstriction | 1992 |
Endothelin-1 synthesis and receptor-mediated activity in porcine lymph vessels.
Topics: Analysis of Variance; Animals; Arginine; Bronchi; Endothelin Receptor Antagonists; Endothelins; Endothelium, Lymphatic; Enzyme Inhibitors; Immunohistochemistry; In Vitro Techniques; Lymphatic System; Mediastinum; Muscle Contraction; Muscle, Smooth; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Piperidines; Receptor, Endothelin A; Receptors, Endothelin; Swine; Trachea | 1996 |
Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; Nitric Oxide; omega-N-Methylarginine; Perfusion; Piperidines; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Renal Agents | 1997 |
Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Topics: Animals; Dose-Response Relationship, Drug; Epithelium; Guinea Pigs; Male; Muscle, Smooth; Neurokinin-1 Receptor Antagonists; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Physalaemin; Piperidines; Pyrrolidonecarboxylic Acid; Quinuclidines; Receptors, Neurokinin-1; Substance P; Tachykinins; Trachea | 1997 |
Pharmacological characterization of endothelin-induced rat pulmonary arterial dilatation.
Topics: Animals; Endothelin-1; Endothelin-3; Enzyme Inhibitors; Male; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation | 1997 |
Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ET(B) receptors in isolated perfused rat liver.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; In Vitro Techniques; Liver; Male; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Oxygen Consumption; Peptide Fragments; Peptides, Cyclic; Piperidines; Portal Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction | 1997 |
Serotonin unmasks functional NK-2 receptors in vagal sensory neurones of the guinea-pig.
Topics: Animals; Benzamides; Cycloheximide; Enzyme Inhibitors; Guinea Pigs; Hydrazines; Imidazoles; Indoles; Male; Membrane Potentials; Neurons, Afferent; Nitric Oxide; Nitric Oxide Donors; Nodose Ganglion; omega-N-Methylarginine; Penicillamine; Piperidines; Protein Synthesis Inhibitors; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin Antagonists; Substance P; Tropisetron | 1999 |
Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Airway Resistance; Animals; Asthma; Benzamides; Bradykinin; Bradykinin Receptor Antagonists; Bronchoconstriction; Citric Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Guinea Pigs; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Piperidines; Receptors, Neurokinin-2 | 1999 |
Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Topics: Angiotensin II; Animals; Drug Combinations; Endothelin-1; Endothelins; Enzyme Inhibitors; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; In Vitro Techniques; Lung; Male; Monocrotaline; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1999 |
Elevation of blood pressure by genetic and pharmacological disruption of the ETB receptor in mice.
Topics: Animals; Blood; Blood Pressure; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelin-1; Gases; Hydrogen-Ion Concentration; Indomethacin; Injections, Intra-Arterial; Mice; Mice, Inbred Strains; Oligopeptides; omega-N-Methylarginine; Osmolar Concentration; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Respiration | 1999 |
Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes.
Topics: 2-Amino-5-phosphonovalerate; Acetylcholine; Alkaloids; Animals; Benzophenanthridines; Choline O-Acetyltransferase; Corpus Striatum; Electrophysiology; Enzyme Inhibitors; Estrenes; Excitatory Amino Acid Antagonists; In Situ Hybridization; Indoles; Interneurons; Membrane Potentials; Mice; Mice, Inbred C57BL; Neurokinin A; Oligopeptides; omega-N-Methylarginine; Peptide Fragments; Phenanthridines; Phosphodiesterase Inhibitors; Piperidines; Pyrrolidinones; Quinoxalines; Quinuclidines; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Receptors, Tachykinin; RNA, Messenger; Signal Transduction; Substance P; Tachykinins; Tetrodotoxin; Tritium | 2000 |
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Topics: Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Enzyme Inhibitors; Forearm; Humans; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; Regional Blood Flow; Vascular Resistance; Vasomotor System | 2000 |
Hypocapnic constriction in rabbit basilar artery in vitro: triggering by N(G)-monomethyl-L-arginine monoacetate and dependence on endothelin-1 and alkalosis.
Topics: Acetylcholine; Alkalies; Alkalosis; Animals; Basilar Artery; Carbon Dioxide; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Hypocapnia; In Vitro Techniques; Male; Oligopeptides; omega-N-Methylarginine; Papaverine; Piperidines; Rabbits; Receptor, Endothelin A; Receptor, Endothelin B; Solutions; Vasoconstriction; Vasodilation; Vasodilator Agents | 2000 |
Endothelin-mediated vasoconstriction in postischemic newborn intestine.
Topics: Animals; Animals, Newborn; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; In Vitro Techniques; Intestine, Small; Ischemia; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; omega-N-Methylarginine; Oxygen; Oxygen Consumption; Perfusion; Piperidines; Receptor, Endothelin A; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Viper Venoms | 2000 |
Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.
Topics: Animals; Blood Flow Velocity; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-3; Enzyme Inhibitors; Fluorescein Angiography; Hemodynamics; Injections; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Rats; Rats, Sprague-Dawley; Retinal Vessels; Vitreous Body | 2000 |
Nitric oxide limits coronary vasoconstriction by a shear stress-dependent mechanism.
Topics: Animals; Coronary Vessels; Dogs; Enzyme Inhibitors; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Piperidines; Vasoconstriction | 2001 |
Acetylcholine-induced contractions in the perforating branch of the human internal mammary artery: protective role of the vascular endothelium.
Topics: Acetylcholine; Atropine; Diamines; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Indomethacin; Mammary Arteries; Middle Aged; Muscarinic Antagonists; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylephrine; Piperidines; Pirenzepine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.
Topics: Adrenergic alpha-Antagonists; Adult; Alleles; Angiotensin II; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Heterotrimeric GTP-Binding Proteins; Heterozygote; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Nitric Oxide Synthase; Norepinephrine; Oligopeptides; omega-N-Methylarginine; Peptides, Cyclic; Piperidines; Protein Subunits; Skin; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 2002 |
Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.
Topics: Animals; Biological Availability; Bridged Bicyclo Compounds; Crystallography, X-Ray; Cyclopropanes; Drug Design; Enzyme Inhibitors; Humans; Imines; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Piperidines; Recombinant Proteins; Structure-Activity Relationship | 2003 |
Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.
Topics: Administration, Oral; Animals; Biological Availability; Drug Design; Enzyme Inhibitors; Humans; Indicators and Reagents; Isoenzymes; Kinetics; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Piperidines; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2003 |
Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart.
Topics: Animals; Calcium-Binding Proteins; Cardiotonic Agents; Cattle; Chromogranin A; Depression, Chemical; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Oxadiazoles; Peptide Fragments; Phosphorylation; Piperidines; Quinoxalines; Rana esculenta; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Stroke Volume | 2008 |